首页> 外文期刊>Epilepsy research >Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: A type II isobolographic analysis
【24h】

Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: A type II isobolographic analysis

机译:普瑞巴林与加巴喷丁,左乙拉西坦,替加滨和维加巴特林在小鼠最大电击诱发癫痫发作模型中的相互作用:II型等效线描记法分析

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to characterize the anticonvulsant effects of pregabalin in combination with four second-generation antiepileptic drugs (i.e., gabapentin, levetiracetam, tiagabine, and vigabatrin) in the mouse maximal electroshock (MES)-induced seizure model by using the type II isobolographic analysis. Tonic hind limb extension (seizure activity) was evoked in adult male albino Swiss mice by a current (sine-wave, 25. mA, 500. V, 50. Hz, 0.2. s stimulus duration) delivered via auricular electrodes. The combination of pregabalin with gabapentin at the fixed-ratio of 1:1 was supra-additive (synergistic) in terms of seizure suppression while the combinations at the fixed-ratios of 2:1 and 4:1 were additive in the mouse MES model. Similarly, the combination of pregabalin with tiagabine at the fixed-ratio of 25:1 was supra-additive, whereas the combinations at the fixed-ratios of 100:1 and 50:1 were additive in the mouse MES model. Pregabalin with levetiracetam and vigabatrin at the fixed-ratios of 1:1, 2:1 and 4:1 were additive in this seizure model. The combinations of pregabalin with gabapentin (1:1) and pregabalin with tiagabine (25:1) appear to be favorable combinations exerting supra-additive interaction in suppressing MES-induced seizures. Pregabalin in combination with levetiracetam and vigabatrin appears to be neutral producing only additivity in the mouse MES model.
机译:这项研究的目的是通过使用以下类型来表征普瑞巴林与四种第二代第二代抗癫痫药(即加巴喷丁,左乙拉西坦,替加滨和维加巴汀)在小鼠最大电击(MES)诱发的癫痫发作模型中的抗惊厥作用II等效线描记法分析。在成年雄性白化病瑞士小鼠中,通过耳电极传递的电流(正弦波,25。mA,500。V,50。Hz,0.2。s刺激持续时间)诱发了强直后肢延伸(癫痫发作活动)。就癫痫发作抑制而言,普瑞巴巴林与加巴喷丁的固定比例为1:1的组合为超加性(协同),而在小鼠MES模型中固定比例为2:1和4:1的组合具有加性。 。同样,在小鼠MES模型中,以25:1的固定比例混合的普瑞巴林与替加滨的组合是超加性的,而以100:1和50:1的固定比例组合的组合是加性的。在这种癫痫发作模型中,普瑞巴林与左乙拉西坦和维加巴汀的固定比例为1:1、2:1和4:1。普瑞巴林与加巴喷丁(1:1)和普瑞巴林与替加滨(25:1)的组合似乎是抑制超微结构抑制MES引起的癫痫发作的超加性相互作用的有利组合。普瑞巴林与左乙拉西坦和维加巴特林合用似乎是中性的,在小鼠MES模型中仅产生可加性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号